Latest period
$2.29B
YoY change
+9.9%
5Y CAGR
+1.1%
Peak year (2023)
$2.62B
Latest annual
$2.21B
Total Liabilities history chart for ResMed (RMD) from 1993 to 2025
Latest: $2.21B
Total Liabilities growth chart for ResMed (RMD) from 1993 to 2025
Latest: +9.9%
Total Liabilities history table for ResMed (RMD) from 1993 to 2025
| 2025 | $2.21B | +9.9% | +$198.18M | ||
| 2024 | $2.01B | -23.4% | −$613.45M | ||
| 2023 | $2.62B | +51.1% | +$886.70M | ||
| 2022 | $1.74B | -5.8% | −$107.34M | ||
| 2021 | $1.84B | -11.9% | −$247.90M | ||
| 2020 | $2.09B | +2.7% | +$54.86M | ||
| 2019 | $2.04B | +102.5% | +$1.03B | ||
| 2018 | $1.00B | -33.4% | −$503.28M | ||
| 2017 | $1.51B | -3.4% | −$53.65M | ||
| 2016 | $1.56B | +162.7% | +$967.41M | ||
| 2015 | $594.47M | -1.4% | −$8.25M | ||
| 2014 | $602.71M | +0.4% | +$2.51M | ||
| 2013 | $600.21M | +13.2% | +$69.96M | ||
| 2012 | $530.24M | +56.8% | +$192.06M | ||
| 2011 | $338.19M | -0.2% | −$676.00K | ||
| 2010 | $338.86M | -13.7% | −$53.91M | ||
| 2009 | $392.78M | +21.1% | +$68.55M | ||
| 2008 | $324.23M | +1.1% | +$3.40M | ||
| 2007 | $320.82M | +19.2% | +$51.75M | ||
| 2006 | $269.07M | -10.3% | −$31.01M | ||
| 2005 | $300.08M | +59.9% | +$112.43M | ||
| 2004 | $187.65M | +8.4% | +$14.49M | ||
| 2003 | $173.16M | -5.5% | −$10.10M | ||
| 2002 | $183.26M | -2.4% | −$4.46M | ||
| 2001 | $187.72M | +768.2% | +$166.10M | ||
| 2000 | $21.62M | +18.2% | +$3.33M | ||
| 1999 | $18.29M | +32.5% | +$4.49M | ||
| 1998 | $13.80M | +34.0% | +$3.50M | ||
| 1997 | $10.30M | +24.1% | +$2.00M | ||
| 1996 | $8.30M | +29.7% | +$1.90M | ||
| 1995 | $6.40M | +60.0% | +$2.40M | ||
| 1994 | $4.00M | +73.9% | +$1.70M | ||
| 1993 | $2.30M | — | — |
- 2025$2.21B+9.9%
- 2024$2.01B-23.4%
- 2023$2.62B+51.1%
- 2022$1.74B-5.8%
- 2021$1.84B-11.9%
- 2020$2.09B+2.7%
- 2019$2.04B+102.5%
- 2018$1.00B-33.4%
- 2017$1.51B-3.4%
- 2016$1.56B+162.7%
- 2015$594.47M-1.4%
- 2014$602.71M+0.4%
- 2013$600.21M+13.2%
- 2012$530.24M+56.8%
- 2011$338.19M-0.2%
- 2010$338.86M-13.7%
- 2009$392.78M+21.1%
- 2008$324.23M+1.1%
- 2007$320.82M+19.2%
- 2006$269.07M-10.3%
- 2005$300.08M+59.9%
- 2004$187.65M+8.4%
- 2003$173.16M-5.5%
- 2002$183.26M-2.4%
- 2001$187.72M+768.2%
- 2000$21.62M+18.2%
- 1999$18.29M+32.5%
- 1998$13.80M+34.0%
- 1997$10.30M+24.1%
- 1996$8.30M+29.7%
- 1995$6.40M+60.0%
- 1994$4.00M+73.9%
- 1993$2.30M—
Total Liabilities values are taken from ResMed's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Liabilities at ResMed (RMD)
According to ResMed's latest reported financial statements, the company's latest reported total liabilities is $2.29B. Total liabilities sum everything the company owes at the end of each reporting period — accounts payable, accrued expenses, debt, lease obligations, and other claims — as filed on the balance sheet. Compare with total assets and total equity for solvency context.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
ResMed (RMD) most recent annual total liabilities stands at $2.21B (2025) – grew 9.9% year-over-year.
ResMed total liabilities compound annual growth for the 2020–2025 (5 years) window is +1.1%, with mixed annual results across the window.
$2.62B stands as the all-time-high annual total liabilities, posted in 2023, against a low of $2.30M during 1993.
ResMed Total Liabilities by Year
ResMed Total Liabilities 2025: $2.21B
2025's total liabilities for ResMed came in at $2.21B, grew 9.9% from 2024.
ResMed Total Liabilities 2024: $2.01B
ResMed posted total liabilities of $2.01B in 2024, declined 23.4% below 2023.
ResMed Total Liabilities 2023: $2.62B
In 2023, ResMed reported total liabilities of $2.62B, surged 51.1% from 2022. This figure represents the highest annual value in the available history.
ResMed Total Liabilities 2022: $1.74B
ResMed total liabilities in 2022 was $1.74B, declined 5.8% below 2021.
ResMed Total Liabilities 2021: $1.84B
ResMed total liabilities in 2021 was $1.84B.
See more financial history for ResMed (RMD).
Sector peers by Total Liabilities
Healthcare peers of ResMed (RMD), ranked by their latest total liabilities
| $207.88B | |
| $137.19B | |
| $117.67B | |
| $85.94B | |
| $84.20B | |
| $81.93B | |
| $65.36B | |
| $54.86B |
- $207.88B
- $137.19B
- $117.67B
- $85.94B
- $84.20B
- $81.93B
- $65.36B
- $54.86B
Frequently asked questions
ResMed (RMD) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation